Bridged bicyclic carboxylic acids for treating osteosarcoma and Ewing sarcoma

Darrell Green; William Fraser

Bridged bicyclic carboxylic acids for treating osteosarcoma and Ewing sarcoma

Darrell Green (Inventor), William Fraser (Inventor)

Research output: Patent

10 Downloads (Pure)

Abstract

The present invention provides a composition for use in a method of treating osteosarcoma, Ewing sarcoma and/or a metastatic cancer originating from osteosarcoma or Ewing sarcoma. The present invention also provides a method of treating a cancer selected from the group consisting of osteosarcoma, Ewing sarcoma, a metastatic cancer originating from an osteosarcoma and a metastatic cancer originating from Ewing sarcoma.

Original language	English
Patent number	PCT/EP/2023/061092
IPC	A61K 31/191,A61P 35/00
Filing date	27/04/23
Publication status	Published - 2 Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

2023 Green & Fraser Patent 2Final published version, 2.39 MB

Cite this

@misc{bf5847e2a91f407f9efcf197358e80a7,

title = "Bridged bicyclic carboxylic acids for treating osteosarcoma and Ewing sarcoma",

abstract = "The present invention provides a composition for use in a method of treating osteosarcoma, Ewing sarcoma and/or a metastatic cancer originating from osteosarcoma or Ewing sarcoma. The present invention also provides a method of treating a cancer selected from the group consisting of osteosarcoma, Ewing sarcoma, a metastatic cancer originating from an osteosarcoma and a metastatic cancer originating from Ewing sarcoma. ",

author = "Darrell Green and William Fraser",

year = "2023",

month = nov,

day = "2",

language = "English",

type = "Patent",

note = "PCT/EP/2023/061092; A61K 31/191,A61P 35/00",

}

TY - PAT

T1 - Bridged bicyclic carboxylic acids for treating osteosarcoma and Ewing sarcoma

AU - Green, Darrell

AU - Fraser, William

PY - 2023/11/2

Y1 - 2023/11/2

N2 - The present invention provides a composition for use in a method of treating osteosarcoma, Ewing sarcoma and/or a metastatic cancer originating from osteosarcoma or Ewing sarcoma. The present invention also provides a method of treating a cancer selected from the group consisting of osteosarcoma, Ewing sarcoma, a metastatic cancer originating from an osteosarcoma and a metastatic cancer originating from Ewing sarcoma.

AB - The present invention provides a composition for use in a method of treating osteosarcoma, Ewing sarcoma and/or a metastatic cancer originating from osteosarcoma or Ewing sarcoma. The present invention also provides a method of treating a cancer selected from the group consisting of osteosarcoma, Ewing sarcoma, a metastatic cancer originating from an osteosarcoma and a metastatic cancer originating from Ewing sarcoma.

M3 - Patent

M1 - PCT/EP/2023/061092

Y2 - 2023/04/27

ER -